Jennifer Humes

Comptroller/Controller/Auditor at ROIVANT SCIENCES LTD.

Net worth: 4 M $ as of 30/06/2026

45 year

76 connections

Health Technology

Finance

Consumer Services

Profile

Jennifer Humes is Chief Accounting Officer at Roivant Sciences Ltd. and Roivant Sciences, Inc., starting in 2025.
Ms. Humes worked at JPMorgan Chase & Co. from 2016 to 2024, serving as Controller-Global Investment Banking in 2024.
Ms. Humes completed undergraduate education at the University of St. Thomas.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ROIVANT SCIENCES LTD. 0.02%	20/06/2026	109,782 ( 0.02% )	4 M $	30/06/2026

Jennifer Humes active positions

Companies	Position	Start
ROIVANT SCIENCES LTD.	Comptroller/Controller/Auditor	20/02/2025
Roivant Sciences, Inc. Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs	Comptroller/Controller/Auditor	20/02/2025

All active positions of Jennifer Humes

Former positions of Jennifer Humes

Companies	Position	End
JPMORGAN CHASE & CO.	Corporate Officer/Principal	01/12/2024

See the detail of Jennifer Humes's experience

Training of Jennifer Humes

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jennifer Humes's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
JPMorgan Chase & Co. JPMorgan Chase & Co. Major BanksFinance Provides banking, asset management, investment banking, credit card and mortgage services	Finance
Roivant Sciences Ltd. Roivant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops restorative therapies for autoimmune diseases	Health Technology
University of St. Thomas University of St. Thomas Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Roivant Sciences, Inc. Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs	Health Technology